Question 1

What is the catalog number for Lck Knockout RAW 264.7 Polyclonal Cells?

Accepted Answer

The catalog number for Lck Knockout RAW 264.7 Polyclonal Cells is ARG12540.

Question 2

What sizes are available for Lck Knockout RAW 264.7 Polyclonal Cells?

Accepted Answer

Lck Knockout RAW 264.7 Polyclonal Cells is available in the following size(s): 1 Million.

Question 3

Is Lck Knockout RAW 264.7 Polyclonal Cells in stock?

Accepted Answer

Lck Knockout RAW 264.7 Polyclonal Cells is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for Lck Knockout RAW 264.7 Polyclonal Cells?

Accepted Answer

Lck Knockout RAW 264.7 Polyclonal Cells is requires dry ice shipping.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Lck Knockout RAW 264.7 Polyclonal Cells

Product Specifications

Type

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

DAPK2 (DAP kinase 2, DAP-kinase-related protein 1, DRP-1, DAPK2)

DAPK2 (DAP kinase 2, DAP-kinase-related protein 1, DRP-1, DAPK2)

Lupartumab (Biosimilar Reference Antibody) (LYPD3)

Lupartumab (Biosimilar Reference Antibody) (LYPD3)

Lupartumab (Biosimilar Reference Antibody) (LYPD3)

Lupartumab (Biosimilar Reference Antibody) (LYPD3)